Travelers Sues Pfizer For $47M Over Epilepsy Drug

Law360, New York (July 18, 2012, 11:09 PM EDT) -- Travelers Indemnity Co. and several of its affiliates on Wednesday filed a $47 million suit against Pfizer Inc. claiming they overpaid for epilepsy drug Neurontin because of its anti-competitive efforts to keep generics out of the market and its aggressive marketing of off-label uses.

In a suit filed in the District of Connecticut, Travelers, the St. Paul Fire and Marine Insurance Co., and the Standard Fire Insurance Co. said that because of Pfizer's deceptive marketing to physicians, the insurers have overpaid millions in connection with workers'...
To view the full article, register now.




Case Information

Case Title

Travelers Indemnity Company et al v. Pfizer Inc. et al

Case Number




Nature of Suit

Fraud or Truth-In-Lending


Vanessa L. Bryant

Date Filed

July 18, 2012

Law Firms


Government Agencies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.